Celina Dubin

Dr. Celina Dubin Feldman, a dermatologist specializing in general and cosmetic dermatology, discusses her co-authored study on telling DRESS (drug reaction with eosinophilia and systemic symptoms) apart from morbilliform drug eruption (MDE) using routine blood work.

Published in Dermatitis, March 2026, the preliminary investigation used machine learning to find that lymphocyte count, pan-immune inflammation value, neutrophil-to-lymphocyte ratio and platelet levels strongly discriminate between the two at first presentation.

Read the study: https://journals.sagepub.com/doi/10.1177/17103568261429251

A case report I co-authored on drug-induced photosensitivity in a patient with vitiligo, published in Case Reports in Dermatological Medicine.

Depigmented skin has no melanocytes and therefore little natural photoprotection. Add a photosensitizing medication and the risk of UV injury rises sharply. In this case a 54-year-old man with vitiligo developed erythematous papules confined to sun-exposed, depigmented skin. The lesions were initially mistaken for a fungal infection; a medication review pointed instead to olmesartan-HCTZ.

The takeaway for clinicians: review the medication list before treating a recurrent rash in vitiliginous skin.

Read the full study: https://pmc.ncbi.nlm.nih.gov/articles/PMC12741891/

Citation report: https://scite.ai/reports/drug-induced-phototoxicity-in-vitiligo-the-1ZAamzRe

Celina Dubin Feldman, MD, is an assistant professor at the Icahn School of Medicine at Mount Sinai and associate program director of the department's residency program.

READ THE COMPLETE STUDY:

https://pmc.ncbi.nlm.nih.gov/articles/PMC12741891/

CITATION REPORT:

https://scite.ai/reports/drug-induced-phototoxicity-in-vitiligo-the-1ZAamzRe

Celina Dubin, MD, attended Robin Hood’s annual gala on May 3, 2026, along with her parents, Glenn Dubin and Eva Andersson-Dubin, MD. The event featured performances by P!nk, the Lumineers, and Pete Davidson and raised $73 million.

READ MORE HERE:

https://www.tradingview.com/news/gurufocus:d0e146f9b094b:0-robin-hood-reaches-70-of-1-billion-endowment-goal/

https://robinhood.org/news/robin-hood-endowment-launch-benefit-2026/

This article was co-authored by Celina Dubin, MD, a dermatology resident at the Icahn School of Medicine at Mount Sinai, and was published in the Journal of Investigative Dermatology.

Read the original abstract here:

https://www.jidonline.org/article/S0022-202X(25)00645-1/fulltext

Celina Dubin, MD, a resident physician in dermatology at the Icahn School of Medicine at Mount Sinai, co-authored this case series study, which was published in the Journal of the American Academy of Dermatology Case Reports.

LEARN MORE IN THE FULL ARTICLE IN JAAD CASE REPORTS HERE:

https://www.jaadcasereports.org/article/S2352-5126(25)00601-0/fulltext

Dr. Celina Dubin, MD, is a resident physician in dermatology at the Icahn School of Medicine at Mount Sinai. She co-authored this case-control study, published in Clinical and Experimental Dermatology.

LEARN MORE ABOUT THIS CASE-CONTROL STUDY IN CED HERE:

https://academic.oup.com/ced/article-abstract/50/9/1856/8141161?redirectedFrom=fulltext

Celina Dubin, MD, a resident physician in dermatology at the Icahn School of Medicine at Mount Sinai, co-authored this phase 2a trial, which appeared in the Journal of the American Academy of Dermatology.

VIEW FULL DETAILS OF THE PHASE 2A TRIAL IN JAAD HERE:

https://www.jaad.org/article/S0190-9622(24)03043-3/fulltext

This research letter was co-authored by Dr. Celina Dubin, MD, a dermatology resident at the Icahn School of Medicine at Mount Sinai, and was published in the Journal of the American Academy of Dermatology International.

SEE THE FULL RANDOMIZATION STUDY IN JAAD INTERNATIONAL HERE:

https://www.jaadinternational.org/article/S2666-3287(24)00108-1/fulltext

Dr. Celina Dubin, MD, is a resident physician in dermatology at the Icahn School of Medicine at Mount Sinai. She co-authored this study, which was published in the Journal of Allergy and Clinical Immunology. The study examines atopic dermatitis (AD), a common inflammatory skin disease that affects up to 10% of adults worldwide.

Read the original paper here:

https://www.jacionline.org/article/S0091-6749(20)30039-7/fulltext

Celina Dubin, MD, a resident physician in dermatology at the Icahn School of Medicine at Mount Sinai, co-authored this study, which appeared in the Journal of the American Academy of Dermatology. The goal of the study was to evaluate the blood proteomic signature of alopecia areata (AA) and identify biomarkers associated with increased disease severity.

Read the original paper here:

https://www.jaad.org/article/S0190-9622(20)30759-3/abstract